A novel LRRFIP1-ALK fusion in inflammatory myofibroblastic tumor of hip and response to crizotinib

Volume: 39, Issue: 1, Pages: 278 - 282
Published: Sep 11, 2020
Abstract
An inflammatory myofibroblastic tumor (IMT) is a rare invasive soft tissue mass with intramuscular penetration that is primarily treated via a surgical procedure. However, with unclear boundaries and a high rate of relapse, there is no standard treatment for recurrence or unresectable tumors. It is noteworthy that approximately half of IMTs harbor genetic rearrangements of the anaplastic lymphoma kinase (ALK). ALK inhibitors have been used...
Paper Details
Title
A novel LRRFIP1-ALK fusion in inflammatory myofibroblastic tumor of hip and response to crizotinib
Published Date
Sep 11, 2020
Volume
39
Issue
1
Pages
278 - 282
Citation AnalysisPro
  • Scinapse’s Top 10 Citation Journals & Affiliations graph reveals the quality and authenticity of citations received by a paper.
  • Discover whether citations have been inflated due to self-citations, or if citations include institutional bias.